|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136.80 SEK | -3.12% |
|
-1.01% | -12.98% |
| 06-17 | Stockholm Stock Exchange trades near flat at the open, OMXS30 unchanged | FW |
| 06-17 | Aktiespararna sees upside in CellaVision after share price collapse: issues buy rating | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 3,263 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | -12.98% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,045 | 2,997 | 2,932 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | -15.12% | -1.57% | -2.17% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 22.5x | 18.7x | 16.3x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 3.31x | 2.99x | 2.68x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -4.3x | 0.9x | 1.1x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 4.23x | 3.78x | 3.43x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 3.95x | 3.48x | 3.09x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 13.3x | 11.2x | 9.71x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 16.6x | 13.5x | 11.5x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 27.6x | 24.1x | 19.7x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 3.62% | 4.14% | 5.07% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.075 | 3.362 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 2.01% | 2.25% | 2.46% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 6.084 | 7.309 | 8.372 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 45.2% | 42.1% | 40.2% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 771.6 | 862.4 | 950.3 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 229 | 268.6 | 302 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 183.9 | 222.7 | 254.9 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 144.9 | 174.1 | 199.4 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -218.2 | -265.9 | -330.9 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 136.80 | 136.80 | 136.80 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.49x | 3.95x | 13.3x | 2.01% | 341M | |
| 57x | 4.55x | 15.19x | 0.38% | 15.48B | |
| 36.59x | - | - | 2.21% | 1.57B | |
| 18.53x | 2.66x | 8.95x | 2.12% | 1.12B | |
| -8.54x | 1.19x | 5.22x | -.--% | 932M | |
| 54.21x | - | - | 0.83% | 554M | |
| 45.29x | - | - | - | 444M | |
| 18.55x | 2.61x | 11.17x | 1.84% | 382M | |
| -14.87x | - | - | - | 335M | |
| Average | 25.47x | 2.99x | 10.77x | 1.34% | 2.35B | |
| Weighted average by Cap. | 47.86x | 4.21x | 14.18x | 0.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
